IL136278A - Thermodynamically stable form of (r)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban), process for its preparation and pharmaceutical compositions comprising it - Google Patents

Thermodynamically stable form of (r)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban), process for its preparation and pharmaceutical compositions comprising it

Info

Publication number
IL136278A
IL136278A IL13627898A IL13627898A IL136278A IL 136278 A IL136278 A IL 136278A IL 13627898 A IL13627898 A IL 13627898A IL 13627898 A IL13627898 A IL 13627898A IL 136278 A IL136278 A IL 136278A
Authority
IL
Israel
Prior art keywords
ramatroban
sulphonyl
carbazole
fluorophenyl
tetrahydro
Prior art date
Application number
IL13627898A
Other languages
English (en)
Other versions
IL136278A0 (en
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of IL136278A0 publication Critical patent/IL136278A0/xx
Publication of IL136278A publication Critical patent/IL136278A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL13627898A 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban), process for its preparation and pharmaceutical compositions comprising it IL136278A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)
PCT/JP1998/005844 WO1999033803A1 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)

Publications (2)

Publication Number Publication Date
IL136278A0 IL136278A0 (en) 2001-05-20
IL136278A true IL136278A (en) 2005-03-20

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13627898A IL136278A (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban), process for its preparation and pharmaceutical compositions comprising it

Country Status (37)

Country Link
US (1) US6362214B1 (zh)
EP (1) EP1051398B1 (zh)
JP (2) JP3817668B2 (zh)
KR (1) KR100586350B1 (zh)
CN (1) CN1140510C (zh)
AR (1) AR013803A1 (zh)
AT (1) ATE263152T1 (zh)
AU (1) AU744242B2 (zh)
BG (1) BG65024B1 (zh)
BR (1) BR9814496A (zh)
CA (1) CA2313230A1 (zh)
CO (1) CO4970800A1 (zh)
DE (2) DE19757983A1 (zh)
DK (1) DK1051398T3 (zh)
ES (1) ES2218874T3 (zh)
GT (1) GT199800198A (zh)
HK (1) HK1034517A1 (zh)
HN (1) HN1998000186A (zh)
HU (1) HUP0004432A3 (zh)
ID (1) ID25446A (zh)
IL (1) IL136278A (zh)
IN (1) IN192932B (zh)
MY (1) MY116312A (zh)
NO (1) NO316618B1 (zh)
NZ (1) NZ504741A (zh)
PE (1) PE20000115A1 (zh)
PL (1) PL341359A1 (zh)
PT (1) PT1051398E (zh)
RU (1) RU2220137C2 (zh)
SI (1) SI1051398T1 (zh)
SK (1) SK285109B6 (zh)
TR (1) TR200001936T2 (zh)
TW (1) TW552258B (zh)
UA (1) UA66832C2 (zh)
UY (2) UY25324A1 (zh)
WO (1) WO1999033803A1 (zh)
ZA (1) ZA9811817B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE543501T1 (de) * 2006-12-20 2012-02-15 Cardoz Ab Kombination von pemirolast und ramatroban zur verwendung bei der behandlung von entzündlichen erkrankungen
AU2007344274A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
US20180021302A1 (en) 2015-02-13 2018-01-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1015711B (zh) * 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1,2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
CN1282320A (zh) 2001-01-31
BR9814496A (pt) 2000-10-10
CO4970800A1 (es) 2000-11-07
NZ504741A (en) 2002-10-25
NO20003217D0 (no) 2000-06-21
AU744242B2 (en) 2002-02-21
HUP0004432A3 (en) 2002-10-28
IN192932B (zh) 2004-06-12
HK1034517A1 (en) 2001-10-26
PL341359A1 (en) 2001-04-09
UY25575A1 (es) 1999-11-17
US6362214B1 (en) 2002-03-26
DE69822882D1 (en) 2004-05-06
JP2001527067A (ja) 2001-12-25
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
ZA9811817B (en) 1999-06-29
DE19757983A1 (de) 1999-07-01
HUP0004432A2 (hu) 2001-06-28
DK1051398T3 (da) 2004-07-19
WO1999033803A1 (en) 1999-07-08
JP3817668B2 (ja) 2006-09-06
NO20003217L (no) 2000-06-21
JP2006151977A (ja) 2006-06-15
MY116312A (en) 2003-12-31
CA2313230A1 (en) 1999-07-08
HN1998000186A (es) 1999-11-03
NO316618B1 (no) 2004-03-08
PE20000115A1 (es) 2000-03-26
EP1051398B1 (en) 2004-03-31
SI1051398T1 (en) 2004-08-31
GT199800198A (es) 1998-12-15
BG104554A (en) 2001-05-31
RU2220137C2 (ru) 2003-12-27
ID25446A (id) 2000-10-05
UA66832C2 (uk) 2004-06-15
AR013803A1 (es) 2001-01-10
IL136278A0 (en) 2001-05-20
CN1140510C (zh) 2004-03-03
AU1687499A (en) 1999-07-19
ES2218874T3 (es) 2004-11-16
JP4411269B2 (ja) 2010-02-10
PT1051398E (pt) 2004-07-30
EP1051398A1 (en) 2000-11-15
TR200001936T2 (tr) 2001-01-22
ATE263152T1 (de) 2004-04-15
KR20010033529A (ko) 2001-04-25
SK9752000A3 (en) 2001-02-12
UY25324A1 (es) 2000-12-29
BG65024B1 (bg) 2006-12-29
DE69822882T2 (de) 2005-02-03
TW552258B (en) 2003-09-11

Similar Documents

Publication Publication Date Title
HUP9801045A3 (en) Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation
HUP9801044A3 (en) Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0003690A3 (en) Polymeric derivatives of camptothecins, process for their preparation and pharmaceutical compositions containing them
HUP0100431A3 (en) Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
HUP0203257A3 (en) Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0102307A3 (en) Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0000383A3 (en) Tetrahydrochinoxalinyl-aminoalkane phosphonic acids, process for their preparation and pharmaceutical compositions thereof
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0002404A3 (en) Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use
HUP0003198A2 (en) Thermodynamically stable modification of 1-(4-carbazoly-loxy)-3-[2-(2-(methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
HUP0000664A3 (en) Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions
HUP0003053A3 (en) Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
IL136278A (en) Thermodynamically stable form of (r)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban), process for its preparation and pharmaceutical compositions comprising it
HUP9700708A3 (en) N-[(9-pyrimido[1,2-a]indolyl)-methyl-phenylacetyl]-phenylglycinol derivatives, pharmaceutical compositions containing them, process for producing them and intermediates
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
HK1055947A1 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1H-Ä1,2,4Ütriazol, methods for producing them and pharmaceutical compositions containing them
AU8031598A (en) 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0001873A3 (en) Amidino-1,4-benzoxazepine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0100019A3 (en) Novel polymorphic forms of cipamfylline, process for their preparation and pharmaceutical compositions thereof
HUP0200868A3 (en) Novel 8a- and 9a-15-membered lactams, process for their preparation, pharmaceutical compositions containing them and their use
AU1606997A (en) Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees